Zota Health Care Limited (NSEI: ZOTA)
Health Care · Pharmaceuticals · IN
Rs1,267.80
-5.15% today · -17.7% 1Y
Zota Health Care Limited (NSEI: ZOTA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $456.03M and employs 635 people.
Over the last twelve months the share price has lost 17.7%, trading between 1.02K and 1.74K.
Tweenvest scores Zota Health Care Limited across four factors: quality 62/100, value 56/100, growth 100/100, dividend 2/100. Its strongest factor is growth.
ZOTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $456.03M
- Revenue (TTM)
- $64.38M
- P/E
- —
- EPS
- -30.08
- Dividend yield
- 0.08%
- Beta (5Y)
- 0.37
- 52-week high
- Rs1,740.00
- 52-week low
- Rs1,022.00
- Avg volume (3M)
- —
- Shares outstanding
- 34.63M
- Employees
- 635
- Next earnings
- —
About Zota Health Care Limited
Zota Health Care Limited is an Indian pharmaceutical firm dedicated to the development, manufacturing, and distribution of a broad spectrum of health-related products across India. Its extensive portfolio encompasses generic medications, over-the-counter (OTC) remedies, traditional Ayurvedic formulations, and nutritional supplements (nutraceuticals). The company places a particular emphasis on supplying treatments for various long-term illnesses, including but not limited to heart disease, diabetes, and thyroid conditions. By March 31, 2021, Zota had established a considerable retail network, operating 591 stores under its DAVAINDIA brand name throughout 24 states in India. The company was founded in 1995 and is currently headquartered in Surat, India.
- ISIN
- INE358U01012
- Founded
- 1995
- Listed since
- May 10, 2017
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tuoxin Pharmaceutical Group Co.,Ltd.SZSE: 301089 | $462.20M | CN¥24.50 | +2.25% |
| ScinoPharm Taiwan, Ltd.TWSE: 1789 | $461.71M | NT$18.60 | -2.11% |
| Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.SZSE: 300452 | $459.87M | CN¥13.26 | +1.07% |
| SMS Pharmaceuticals LimitedNSEI: SMSPHARMA | $458.43M | Rs471.30 | -0.78% |
| AgomAb Therapeutics NVNasdaqGS: AGMB | $454.07M | $9.22 | +4.77% |
| JW Pharmaceutical CorporationKOSE: A001060 | $453.55M | ₩26,750.00 | -0.37% |
| DHG Pharmaceutical Joint Stock CompanyHOSE: DHG | $449.83M | ₫89,400.00 | -0.78% |
| Lumosa Therapeutics Co., Ltd.TPEX: 6535 | $446.91M | NT$85.00 | +5.59% |
Figures last refreshed Oct 4, 2026.